Maleimide-functionalised platinum(iv) complexes as a synthetic platform for targeted drug delivery

What do we know about the reduction of Pt(IV) pro-drugs?

(2012) Ezequiel Wexselblatt et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Mono-carboxylated diaminedichloridoplatinum(iv) complexes – selective synthesis, characterization, and cytotoxicity

(2011) Verena Pichler et al.   DALTON TRANSACTIONS

Albumin binding ligands and albumin conjugate uptake by cancer cells

(2011) Eva Frei   Diabetology & Metabolic Syndrome

Redox metabolism and malignancy

(2010) Christina L Grek et al.   CURRENT OPINION IN PHARMACOLOGY

The status of platinum anticancer drugs in the clinic and in clinical trials

(2010) Nial J. Wheate et al.   DALTON TRANSACTIONS

Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads

(2009) Shanta Dhar et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue

(2008) H. Choy et al.   CLINICAL CANCER RESEARCH

Resistance against novel anticancer metal compounds: Differences and similarities

(2008) P HEFFETER et al.   DRUG RESISTANCE UPDATES

Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles

(2008) Felix Kratz   JOURNAL OF CONTROLLED RELEASE

Targeted Single-Wall Carbon Nanotube-Mediated Pt(IV) Prodrug Delivery Using Folate as a Homing Device

(2008) Shanta Dhar et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY